TMTakashi Mori

Takashi Mori

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takashi Mori has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Radiation therapy for persistent or progressive mediastinal lymphoma after chemotherapy in FeLV ‐positive cats: a retrospective case series of four cats

    by A Uno, T Hasegawa, T Mori

    Background: Mediastinal lymphoma in feline leukaemia virus (FeLV)‐positive cats is associated with a poor prognosis, and therapeutic options may be limited when adequate disease control is not achieved with chemotherapy. The efficacy of radiation therapy in this setting has not been established. Case Report: Medical records were retrospectively reviewed for FeLV‐positive cats diagnosed with mediastinal lymphoma between November 2018 and December 2024 that had persistent or progressive mediastinal disease after chemotherapy and were subsequently treated with radiation therapy. Treatment response was assessed by computed tomography using the Response Evaluation Criteria in Solid Tumours (RECIST). Three of four cats (75%) responded to radiation therapy (two complete responses, one partial response). Respiratory signs improved rapidly in three cats (median 5 days). Local disease control was achieved in most cases; however, three cats developed progression at other sites. Survival times were 45, 150 and 352 days in cats that died, and one cat remained alive for >626 days at the time of last follow‐up. No severe radiation‐related adverse effects were documented during the available follow‐up, although systematic evaluation of late radiation toxicity was not possible. Conclusion: Radiation therapy may provide local control and rapid palliation of respiratory signs in FeLV‐positive cats with persistent or progressive mediastinal lymphoma after chemotherapy. Further studies with larger cohorts are warranted.

  • Open Access

    A dose‐escalated radiation protocol of 10 × 4.0 Gy provides long‐term local control in canine apocrine gland anal sac adenocarcinoma

    by M. Terauchi, Y. Fujii, R. Iwasaki, T. Mori

    Objectives: To obtain insights for establishing radiation therapy strategies that provide long‐term locoregional benefits in canine apocrine gland anal sac adenocarcinoma, we evaluated whether a dose‐escalated protocol (10 × 4.0 Gy) could improve clinical outcomes, particularly long‐term locoregional control, while maintaining acceptable toxicity. Materials and Methods: This retrospective cohort study included dogs with apocrine gland anal sac adenocarcinoma treated with three‐dimensional conformal radiation therapy between September 2016 and September 2025. Dogs administered chemotherapy agents other than toceranib phosphate were excluded. Dogs were classified according to the radiation therapy protocol received as the dose‐escalated protocol group (10 × 4.0 Gy; Group A, n = 15) or the comparison group (8 × 3.8 Gy; Group B, n = 11). Outcomes included overall survival, progression‐free survival, local progression‐free survival and radiation‐related adverse effects. Results: The median overall survival, progression‐free survival and local progression‐free survival of Group A (1534, 926 and 1554 days, respectively) were significantly longer than those of Group B (821, 258 and 351 days, respectively). The treatment response rate based on the 3‐month follow‐up CT examination was higher in Group A (90.9%) than in Group B (10.0%). The 1‐year local progression‐free survival rate was also higher in Group A (93.3%) than in Group B (45.5%). Additionally, all observed radiation‐related adverse effects were clinically manageable. Clinical Significance: This retrospective cohort study demonstrated that the dose‐escalated 10 × 4.0 Gy protocol was associated with improved locoregional control and clinically manageable toxicity. Our findings suggest that dose escalation in apocrine gland anal sac adenocarcinoma therapy can be an effective strategy when sustained locoregional control is a clinical priority.

  • Open Access

    Data from Deuterium Magnetic Resonance Imaging Using Deuterated Water-Induced 2H-Tissue Labeling Allows Monitoring Cancer Treatment at Clinical Field Strength

    by Hirofumi Asano, Abdelazim Elsayed Elhelaly, Fuminori Hyodo, Ryota Iwasaki, Yoshifumi Noda, Hiroki Kato, Koki Ichihashi, Hiroyuki Tomita, Masaharu Murata, Takashi Mori, et al.

    Purpose:An accurate and noninvasive assessment of tumor response following treatment other than traditional anatomical imaging techniques is essential. Deuterium magnetic resonance spectroscopic (MRS) imaging has been demonstrated as an alternative for cancer metabolic imaging by high-field MRI using deuterium-labeled molecules. The study aim was to use 2H tissue labeling and deuterium MRI at clinical field strength for tumor visualization and assessment of three anticancer therapies in pancreatic cancer model mice.Experimental Design:MIA PaCa-2 pancreatic carcinoma and C26 colorectal carcinoma models of BALB/c-nu mice was prepared, and repeated deuterium MRI was performed during the first 10 days of free drinking of 30% D2O to track 2H distribution in tissues. 2H accumulation in the tumor after irradiation, bevacizumab administration, or gemcitabine administration was also measured in MIA PaCa-2–bearing mice. Confirmatory proton MRI, ex vivo metabolic hyperpolarization 13C-MRS, and histopathology were performed.Results:The mouse's whole-body distribution of 2H was visible 1 day after drinking, and the signal intensity increased daily. Although the tumor size did not change 1 and 3 days after irradiation, the amount of 2H decreased significantly. The 2H image intensity of the tumor also significantly decreased after the administration of bevacizumab or gemcitabine. Metabolic hyperpolarization 13C-MRS, proton MRI, and 2H-NMR spectroscopy confirmed the efficacy of the anticancer treatments.Conclusions:Deuterium MRI at 1.5T proved feasible to track 2H distribution throughout mouse tissues during D2O administration and revealed a higher 2H accumulation in the tumor xenografts. This research demonstrated a promising successful method for preliminary assessment of radiotherapy and chemotherapy of cancer.

  • Open Access

    Data from Deuterium Magnetic Resonance Imaging Using Deuterated Water-Induced 2H-Tissue Labeling Allows Monitoring Cancer Treatment at Clinical Field Strength

    by Hirofumi Asano, Abdelazim Elsayed Elhelaly, Fuminori Hyodo, Ryota Iwasaki, Yoshifumi Noda, Hiroki Kato, Koki Ichihashi, Hiroyuki Tomita, Masaharu Murata, Takashi Mori, et al.

    Purpose:An accurate and noninvasive assessment of tumor response following treatment other than traditional anatomical imaging techniques is essential. Deuterium magnetic resonance spectroscopic (MRS) imaging has been demonstrated as an alternative for cancer metabolic imaging by high-field MRI using deuterium-labeled molecules. The study aim was to use 2H tissue labeling and deuterium MRI at clinical field strength for tumor visualization and assessment of three anticancer therapies in pancreatic cancer model mice.Experimental Design:MIA PaCa-2 pancreatic carcinoma and C26 colorectal carcinoma models of BALB/c-nu mice was prepared, and repeated deuterium MRI was performed during the first 10 days of free drinking of 30% D2O to track 2H distribution in tissues. 2H accumulation in the tumor after irradiation, bevacizumab administration, or gemcitabine administration was also measured in MIA PaCa-2–bearing mice. Confirmatory proton MRI, ex vivo metabolic hyperpolarization 13C-MRS, and histopathology were performed.Results:The mouse's whole-body distribution of 2H was visible 1 day after drinking, and the signal intensity increased daily. Although the tumor size did not change 1 and 3 days after irradiation, the amount of 2H decreased significantly. The 2H image intensity of the tumor also significantly decreased after the administration of bevacizumab or gemcitabine. Metabolic hyperpolarization 13C-MRS, proton MRI, and 2H-NMR spectroscopy confirmed the efficacy of the anticancer treatments.Conclusions:Deuterium MRI at 1.5T proved feasible to track 2H distribution throughout mouse tissues during D2O administration and revealed a higher 2H accumulation in the tumor xenografts. This research demonstrated a promising successful method for preliminary assessment of radiotherapy and chemotherapy of cancer.

  • Open Access

    Deuterium Magnetic Resonance Imaging Using Deuterated Water-Induced 2H-Tissue Labeling Allows Monitoring Cancer Treatment at Clinical Field Strength

    by Hirofumi Asano, Abdelazim Elsayed. Elhelaly, Fuminori Hyodo, Ryota Iwasaki, Yoshifumi Noda, Hiroki Kato, Koki Ichihashi, Hiroyuki Tomita, Masaharu Murata, Takashi Mori, et al.

    Purpose: An accurate and noninvasive assessment of tumor response following treatment other than traditional anatomical imaging techniques is essential. Deuterium magnetic resonance spectroscopic (MRS) imaging has been demonstrated as an alternative for cancer metabolic imaging by high-field MRI using deuterium-labeled molecules. The study aim was to use 2H tissue labeling and deuterium MRI at clinical field strength for tumor visualization and assessment of three anticancer therapies in pancreatic cancer model mice. Experimental Design: MIA PaCa-2 pancreatic carcinoma and C26 colorectal carcinoma models of BALB/c-nu mice was prepared, and repeated deuterium MRI was performed during the first 10 days of free drinking of 30% D2O to track 2H distribution in tissues. 2H accumulation in the tumor after irradiation, bevacizumab administration, or gemcitabine administration was also measured in MIA PaCa-2–bearing mice. Confirmatory proton MRI, ex vivo metabolic hyperpolarization 13C-MRS, and histopathology were performed. Results: The mouse's whole-body distribution of 2H was visible 1 day after drinking, and the signal intensity increased daily. Although the tumor size did not change 1 and 3 days after irradiation, the amount of 2H decreased significantly. The 2H image intensity of the tumor also significantly decreased after the administration of bevacizumab or gemcitabine. Metabolic hyperpolarization 13C-MRS, proton MRI, and 2H-NMR spectroscopy confirmed the efficacy of the anticancer treatments. Conclusions: Deuterium MRI at 1.5T proved feasible to track 2H distribution throughout mouse tissues during D2O administration and revealed a higher 2H accumulation in the tumor xenografts. This research demonstrated a promising successful method for preliminary assessment of radiotherapy and chemotherapy of cancer.


  • Open Access

    Free Radical Imaging for Visualization of Radiation Treatment Using Dynamic Nuclear Polarization (DNP) MRI

    by F. Hyodo, K. Koyasu, T. Yamaguchi, R. Iwasaki, H. Tanaka, S. Shoda, M. Takasu, T. Mori, M. Matsuo


  • Transcription profile of chemokine receptors, cytokines and cytotoxic markers in peripheral blood of dogs with epitheliotropic cutaneous lymphoma

    by Naoki Chimura, Aki Iio, Eiji Ozaki, Takashi Mori, Yusuke Ito, Nobuo Murayama, Masahiko Nagata, Kaori Ide, Koji Nishifuji, Hiroaki Kamishina, et al.

    Mycosis fungoides (MF) is the most common form of canine epitheliotropic cutaneous lymphoma, which is characterized by the accumulation of neoplastic CD8(+) T cells. Given that multifocal skin lesions are commonly seen in MF, neoplastic lymphocytes may actively migrate into the blood circulation. Cytotoxic T cells with a skin-homing phenotype could be increased in the blood circulation of dogs with MF. Ten dogs with MF and 10 age-matched healthy dogs were included. The transcription levels of chemokine receptors, cytokines and cytotoxic markers in peripheral blood of dogs with MF were quantified by real-time RT-PCR. The dogs with MF had lower transcription levels of chemokine receptors associated with skin homing (CCR4), epitheliotropism (CXCR3), lymph node homing (CCR7), a type-1 cytokine (LT-α) and cytotoxic markers (perforin and granzyme B) in the circulation than healthy control dogs (P < 0.05). The present results suggest that the number of peripheral cytotoxic T cells with a skin-homing phenotype could be decreased in the peripheral blood of dogs with MF, which might be due to the sequestration of cytotoxic T cells in the lesional skin.


  • Open Access

    Giant Hypertrophic Gastritis in a Dog Treated with Surgical Resection

    by Yukako Mitake, Takashi Mori, Yuki Hoshino, Yusuke Ito, Sadatoshi Maeda, Atsuko Murai, Hiroki Sakai, Kohji Maruo

    10歳,雄のシェットランド・シープドッグが吐血,重度貧血を主訴に胃の精査目的のため来院した.血液検査では重度貧血があり,血液生化学検査では低蛋白血症がみられた.腹部X線検査にて胃の不透過性亢進,胃拡張があり,超音波検査にて胃内腔を占拠する実質性の内容物を認めた.虚脱し起立不能で一般状態が悪かったため,輸血を行いながら緊急的に試験開腹を実施した.胃切開により胃の大弯粘膜面に巨大な脳回状腫瘤を確認した.重度貧血の原因がその病変にあると考え,胃の部分切除を行った.病理組織検査において表層粘膜上皮の過形成があり,細胞異型性は認められなかったことから,巨大肥厚性胃炎と診断された.術後,貧血と低蛋白血症は徐々に回復した.犬は術後1年を経過した現在も再発はなく経過良好である.

  • Open Access

    Adenosquamous Carcinomas of the Larynx and Orbit in Two Dogs

    by Akira Murakami, Takashi Mori, Yuki Hoshino, Nao Iwatani, Mami Murakami, Hiroki Sakai, Kohji Maruo

    総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。

  • Open Access

    Long-Term Use of Palate Cap for Repair of an Acquired Palatal Defect in a Dog and a Cat

    by Yusuke Ito, Kazuhiro Watanabe, Takashi Mori, Shigeo Yamada, Masaya Suzuki, Yuki Hoshino, Nao Iwatani, Kohji Maruo